Delcath Systems, Inc. (NASDAQ: DCTH) Stock Competitors & Peer Comparison
See DCTH's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for DCTH and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DCTH | $16.11 | +4.14% | 521.6M | 1511.00 | $0.01 | N/A |
| ABT | $108.76 | +0.74% | 186.5B | 20.69 | $5.21 | +2.31% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $342.09 | +1.38% | 130B | 25.32 | $13.39 | +1.03% |
| MDT | $88.87 | +3.43% | 111.6B | 15.76 | $5.53 | +3.29% |
| BSX | $50.55 | +2.54% | 73.3B | 15.91 | $3.10 | N/A |
| EW | $92.37 | +3.41% | 51.7B | 33.23 | $2.70 | N/A |
| DXCM | $87.75 | +5.70% | 32B | 36.37 | $2.33 | N/A |
| RMD | $218.44 | -2.15% | 30.7B | 19.68 | $10.77 | +1.15% |
| PHG | $26.88 | +2.09% | 26.1B | 15.28 | $1.75 | +3.70% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
DCTH vs ABT Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ABT has a market cap of 186.5B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ABT trades at $108.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ABT's P/E ratio is 20.69. In terms of profitability, DCTH's ROE is +0.00%, compared to ABT's ROE of +0.11%. Regarding short-term risk, DCTH is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
DCTH vs BSX-PA Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, DCTH's ROE is +0.00%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, DCTH is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
DCTH vs SYK Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, SYK has a market cap of 130B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while SYK trades at $342.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas SYK's P/E ratio is 25.32. In terms of profitability, DCTH's ROE is +0.00%, compared to SYK's ROE of +0.16%. Regarding short-term risk, DCTH is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SYK's competition here
Medtronic plc (NYSE: MDT)
DCTH vs MDT Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, MDT has a market cap of 111.6B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while MDT trades at $88.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas MDT's P/E ratio is 15.76. In terms of profitability, DCTH's ROE is +0.00%, compared to MDT's ROE of +0.10%. Regarding short-term risk, DCTH is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
DCTH vs BSX Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, BSX has a market cap of 73.3B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while BSX trades at $50.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas BSX's P/E ratio is 15.91. In terms of profitability, DCTH's ROE is +0.00%, compared to BSX's ROE of +0.15%. Regarding short-term risk, DCTH is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
DCTH vs EW Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, EW has a market cap of 51.7B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while EW trades at $92.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas EW's P/E ratio is 33.23. In terms of profitability, DCTH's ROE is +0.00%, compared to EW's ROE of +0.10%. Regarding short-term risk, DCTH is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
DCTH vs DXCM Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, DXCM has a market cap of 32B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while DXCM trades at $87.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas DXCM's P/E ratio is 36.37. In terms of profitability, DCTH's ROE is +0.00%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, DCTH is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
DCTH vs RMD Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, RMD has a market cap of 30.7B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while RMD trades at $218.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas RMD's P/E ratio is 19.68. In terms of profitability, DCTH's ROE is +0.00%, compared to RMD's ROE of +0.24%. Regarding short-term risk, DCTH is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
DCTH vs PHG Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, PHG has a market cap of 26.1B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while PHG trades at $26.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas PHG's P/E ratio is 15.28. In terms of profitability, DCTH's ROE is +0.00%, compared to PHG's ROE of +0.10%. Regarding short-term risk, DCTH is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
DCTH vs ZBH Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ZBH has a market cap of 18.7B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ZBH trades at $96.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ZBH's P/E ratio is 11.38. In terms of profitability, DCTH's ROE is +0.00%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, DCTH is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
DCTH vs ABMD Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ABMD's P/E ratio is 65.36. In terms of profitability, DCTH's ROE is +0.00%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, DCTH is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
DCTH vs PEN Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, PEN has a market cap of 12.8B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while PEN trades at $326.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas PEN's P/E ratio is 84.77. In terms of profitability, DCTH's ROE is +0.00%, compared to PEN's ROE of +0.11%. Regarding short-term risk, DCTH is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
DCTH vs SNN Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, SNN has a market cap of 12.6B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while SNN trades at $29.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas SNN's P/E ratio is 14.16. In terms of profitability, DCTH's ROE is +0.00%, compared to SNN's ROE of +0.12%. Regarding short-term risk, DCTH is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SNN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
DCTH vs SWAV Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas SWAV's P/E ratio is 78.76. In terms of profitability, DCTH's ROE is +0.00%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, DCTH is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
DCTH vs ALGN Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ALGN has a market cap of 12.4B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ALGN trades at $175.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ALGN's P/E ratio is 15.83. In terms of profitability, DCTH's ROE is +0.00%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, DCTH is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
DCTH vs GMED Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, GMED has a market cap of 11.1B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while GMED trades at $84.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas GMED's P/E ratio is 18.56. In terms of profitability, DCTH's ROE is +0.00%, compared to GMED's ROE of +0.12%. Regarding short-term risk, DCTH is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
DCTH vs GKOS Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while GKOS trades at $181.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas GKOS's P/E ratio is -209.45. In terms of profitability, DCTH's ROE is +0.00%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, DCTH is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
DCTH vs PODD Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, PODD has a market cap of 9.8B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while PODD trades at $142.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas PODD's P/E ratio is 24.05. In terms of profitability, DCTH's ROE is +0.00%, compared to PODD's ROE of +0.27%. Regarding short-term risk, DCTH is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
DCTH vs BIO-B Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while BIO-B trades at $349.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas BIO-B's P/E ratio is 103.54. In terms of profitability, DCTH's ROE is +0.00%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, DCTH is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
DCTH vs BIO Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, BIO has a market cap of 9.5B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while BIO trades at $351.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas BIO's P/E ratio is 38.00. In terms of profitability, DCTH's ROE is +0.00%, compared to BIO's ROE of +0.03%. Regarding short-term risk, DCTH is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BIO's competition here
Masimo Corporation (NASDAQ: MASI)
DCTH vs MASI Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas MASI's P/E ratio is 44.43. In terms of profitability, DCTH's ROE is +0.00%, compared to MASI's ROE of +0.09%. Regarding short-term risk, DCTH is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
DCTH vs BRKR Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, BRKR has a market cap of 8.1B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while BRKR trades at $55.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas BRKR's P/E ratio is 26.84. In terms of profitability, DCTH's ROE is +0.00%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, DCTH is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
DCTH vs NARI Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas NARI's P/E ratio is -59.24. In terms of profitability, DCTH's ROE is +0.00%, compared to NARI's ROE of -0.00%. Regarding short-term risk, DCTH is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
DCTH vs ITGR Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ITGR trades at $125.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ITGR's P/E ratio is 19.72. In terms of profitability, DCTH's ROE is +0.00%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, DCTH is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
DCTH vs IRTC Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, IRTC has a market cap of 4.2B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while IRTC trades at $124.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas IRTC's P/E ratio is -199.75. In terms of profitability, DCTH's ROE is +0.00%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, DCTH is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check IRTC's competition here
LivaNova PLC (NASDAQ: LIVN)
DCTH vs LIVN Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while LIVN trades at $75.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas LIVN's P/E ratio is 18.10. In terms of profitability, DCTH's ROE is +0.00%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, DCTH is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check LIVN's competition here
Haemonetics Corporation (NYSE: HAE)
DCTH vs HAE Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, HAE has a market cap of 4B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while HAE trades at $86.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas HAE's P/E ratio is 17.54. In terms of profitability, DCTH's ROE is +0.00%, compared to HAE's ROE of +0.11%. Regarding short-term risk, DCTH is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check HAE's competition here
Axonics, Inc. (NASDAQ: AXNX)
DCTH vs AXNX Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas AXNX's P/E ratio is -709.80. In terms of profitability, DCTH's ROE is +0.00%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, DCTH is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
DCTH vs TMDX Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while TMDX trades at $87.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas TMDX's P/E ratio is 42.58. In terms of profitability, DCTH's ROE is +0.00%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, DCTH is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
DCTH vs AXGN Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while AXGN trades at $47.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas AXGN's P/E ratio is 122.18. In terms of profitability, DCTH's ROE is +0.00%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, DCTH is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
DCTH vs UFPT Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, UFPT has a market cap of 2.4B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while UFPT trades at $318.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas UFPT's P/E ratio is 32.07. In terms of profitability, DCTH's ROE is +0.00%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, DCTH is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
DCTH vs BFLY Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, BFLY has a market cap of 2.3B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while BFLY trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas BFLY's P/E ratio is -36.77. In terms of profitability, DCTH's ROE is +0.00%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, DCTH is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
DCTH vs ESTA Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ESTA has a market cap of 2.3B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ESTA trades at $75.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ESTA's P/E ratio is -61.44. In terms of profitability, DCTH's ROE is +0.00%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, DCTH is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
DCTH vs NUVA Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas NUVA's P/E ratio is 75.00. In terms of profitability, DCTH's ROE is +0.00%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, DCTH is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
DCTH vs NVCR Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while NVCR trades at $17.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas NVCR's P/E ratio is -10.71. In terms of profitability, DCTH's ROE is +0.00%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, DCTH is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
DCTH vs INSP Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while INSP trades at $60.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas INSP's P/E ratio is 26.51. In terms of profitability, DCTH's ROE is +0.00%, compared to INSP's ROE of +0.18%. Regarding short-term risk, DCTH is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
DCTH vs TNDM Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while TNDM trades at $22.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas TNDM's P/E ratio is -20.35. In terms of profitability, DCTH's ROE is +0.00%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, DCTH is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check TNDM's competition here
Enovis Corporation (NYSE: ENOV)
DCTH vs ENOV Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ENOV trades at $24.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ENOV's P/E ratio is 7.62. In terms of profitability, DCTH's ROE is +0.00%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, DCTH is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ENOV's competition here
CONMED Corporation (NYSE: CNMD)
DCTH vs CNMD Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while CNMD trades at $49.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas CNMD's P/E ratio is 10.78. In terms of profitability, DCTH's ROE is +0.00%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, DCTH is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
DCTH vs ATEC Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ATEC trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ATEC's P/E ratio is -155.17. In terms of profitability, DCTH's ROE is +0.00%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, DCTH is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ATEC's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
DCTH vs IART Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while IART trades at $17.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas IART's P/E ratio is 7.31. In terms of profitability, DCTH's ROE is +0.00%, compared to IART's ROE of -0.01%. Regarding short-term risk, DCTH is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
DCTH vs AORT Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while AORT trades at $26.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas AORT's P/E ratio is 45.28. In terms of profitability, DCTH's ROE is +0.00%, compared to AORT's ROE of -0.01%. Regarding short-term risk, DCTH is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
DCTH vs HSKA Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas HSKA's P/E ratio is -62.49. In terms of profitability, DCTH's ROE is +0.00%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, DCTH is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check HSKA's competition here
IRadimed Corporation (NASDAQ: IRMD)
DCTH vs IRMD Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while IRMD trades at $91.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas IRMD's P/E ratio is 46.48. In terms of profitability, DCTH's ROE is +0.00%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, DCTH is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check IRMD's competition here
Avanos Medical, Inc. (NYSE: AVNS)
DCTH vs AVNS Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas AVNS's P/E ratio is 27.77. In terms of profitability, DCTH's ROE is +0.00%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, DCTH is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check AVNS's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
DCTH vs PRCT Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while PRCT trades at $21.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas PRCT's P/E ratio is -10.52. In terms of profitability, DCTH's ROE is +0.00%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, DCTH is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check PRCT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
DCTH vs SILK Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas SILK's P/E ratio is -18.96. In terms of profitability, DCTH's ROE is +0.00%, compared to SILK's ROE of -0.35%. Regarding short-term risk, DCTH is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SILK's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
DCTH vs LMRI Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while LMRI trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas LMRI's P/E ratio is -22.53. In terms of profitability, DCTH's ROE is +0.00%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, DCTH is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check LMRI's competition here
Paragon 28, Inc. (NYSE: FNA)
DCTH vs FNA Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas FNA's P/E ratio is -19.83. In terms of profitability, DCTH's ROE is +0.00%, compared to FNA's ROE of -0.35%. Regarding short-term risk, DCTH is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
DCTH vs BVS Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, BVS has a market cap of 956.9M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while BVS trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas BVS's P/E ratio is 18.59. In terms of profitability, DCTH's ROE is +0.00%, compared to BVS's ROE of +0.28%. Regarding short-term risk, DCTH is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BVS's competition here
InMode Ltd. (NASDAQ: INMD)
DCTH vs INMD Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, INMD has a market cap of 880M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while INMD trades at $15.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas INMD's P/E ratio is 10.63. In terms of profitability, DCTH's ROE is +0.00%, compared to INMD's ROE of +0.13%. Regarding short-term risk, DCTH is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check INMD's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
DCTH vs AVR Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, AVR has a market cap of 866.3M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while AVR trades at $9.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas AVR's P/E ratio is -4.00. In terms of profitability, DCTH's ROE is +0.00%, compared to AVR's ROE of -1.24%. Regarding short-term risk, DCTH is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
DCTH vs CSII Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas CSII's P/E ratio is -20.83. In terms of profitability, DCTH's ROE is +0.00%, compared to CSII's ROE of -0.14%. Regarding short-term risk, DCTH is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
DCTH vs SIBN Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, SIBN has a market cap of 825.3M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while SIBN trades at $18.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas SIBN's P/E ratio is -54.74. In terms of profitability, DCTH's ROE is +0.00%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, DCTH is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SIBN's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
DCTH vs AHCO Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, AHCO has a market cap of 774.1M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while AHCO trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas AHCO's P/E ratio is 11.61. In terms of profitability, DCTH's ROE is +0.00%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, DCTH is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
DCTH vs SSII Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, SSII has a market cap of 754.5M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while SSII trades at $3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas SSII's P/E ratio is -73.53. In terms of profitability, DCTH's ROE is +0.00%, compared to SSII's ROE of -0.23%. Regarding short-term risk, DCTH is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SSII's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
DCTH vs BBNX Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, BBNX has a market cap of 715.3M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while BBNX trades at $16.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas BBNX's P/E ratio is -10.53. In terms of profitability, DCTH's ROE is +0.00%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, DCTH is more volatile compared to BBNX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BBNX's competition here
CeriBell, Inc. (NASDAQ: CBLL)
DCTH vs CBLL Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, CBLL has a market cap of 713.7M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while CBLL trades at $19.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas CBLL's P/E ratio is -11.54. In terms of profitability, DCTH's ROE is +0.00%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, DCTH is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CBLL's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
DCTH vs TCMD Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, TCMD has a market cap of 665.4M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while TCMD trades at $29.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas TCMD's P/E ratio is 33.52. In terms of profitability, DCTH's ROE is +0.00%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, DCTH is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check TCMD's competition here
Surmodics, Inc. (NASDAQ: SRDX)
DCTH vs SRDX Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas SRDX's P/E ratio is -34.66. In terms of profitability, DCTH's ROE is +0.00%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, DCTH is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SRDX's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
DCTH vs BWAY Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, BWAY has a market cap of 608M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while BWAY trades at $15.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas BWAY's P/E ratio is 39.38. In terms of profitability, DCTH's ROE is +0.00%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, DCTH is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
DCTH vs KIDS Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, KIDS has a market cap of 584.8M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while KIDS trades at $23.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas KIDS's P/E ratio is -19.30. In terms of profitability, DCTH's ROE is +0.00%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, DCTH is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
DCTH vs APEN Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas APEN's P/E ratio is -9.43. In terms of profitability, DCTH's ROE is +0.00%, compared to APEN's ROE of -0.85%. Regarding short-term risk, DCTH is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check APEN's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
DCTH vs CTKB Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, CTKB has a market cap of 542.4M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while CTKB trades at $4.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas CTKB's P/E ratio is -22.25. In terms of profitability, DCTH's ROE is +0.00%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, DCTH is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CTKB's competition here
ZimVie Inc. (NASDAQ: ZIMV)
DCTH vs ZIMV Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, DCTH's ROE is +0.00%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, DCTH is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ZIMV's competition here
Varex Imaging Corporation (NASDAQ: VREX)
DCTH vs VREX Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, VREX has a market cap of 522.5M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while VREX trades at $18.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas VREX's P/E ratio is 13.06. In terms of profitability, DCTH's ROE is +0.00%, compared to VREX's ROE of -0.18%. Regarding short-term risk, DCTH is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check VREX's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
DCTH vs NPCE Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, NPCE has a market cap of 505.6M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while NPCE trades at $14.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas NPCE's P/E ratio is -25.57. In terms of profitability, DCTH's ROE is +0.00%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, DCTH is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check NPCE's competition here
Cerus Corporation (NASDAQ: CERS)
DCTH vs CERS Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, CERS has a market cap of 473.6M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while CERS trades at $2.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas CERS's P/E ratio is -46.91. In terms of profitability, DCTH's ROE is +0.00%, compared to CERS's ROE of -0.10%. Regarding short-term risk, DCTH is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CERS's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
DCTH vs CLPT Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, CLPT has a market cap of 426.2M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while CLPT trades at $14.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas CLPT's P/E ratio is -12.04. In terms of profitability, DCTH's ROE is +0.00%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, DCTH is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CLPT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
DCTH vs OFIX Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, OFIX has a market cap of 415.5M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while OFIX trades at $10.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas OFIX's P/E ratio is -13.43. In terms of profitability, DCTH's ROE is +0.00%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, DCTH is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check OFIX's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
DCTH vs SGHT Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, SGHT has a market cap of 406.4M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while SGHT trades at $7.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas SGHT's P/E ratio is -13.34. In terms of profitability, DCTH's ROE is +0.00%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, DCTH is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
DCTH vs CARL Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, CARL has a market cap of 375.7M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while CARL trades at $13.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas CARL's P/E ratio is -9.66. In terms of profitability, DCTH's ROE is +0.00%, compared to CARL's ROE of -0.38%. Regarding short-term risk, DCTH is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
DCTH vs PACB Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, PACB has a market cap of 368.1M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while PACB trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas PACB's P/E ratio is -2.89. In terms of profitability, DCTH's ROE is +0.00%, compared to PACB's ROE of -49.62%. Regarding short-term risk, DCTH is more volatile compared to PACB. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check PACB's competition here
CapsoVision, Inc. (NASDAQ: CV)
DCTH vs CV Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, CV has a market cap of 354.7M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while CV trades at $6.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas CV's P/E ratio is -2.84. In terms of profitability, DCTH's ROE is +0.00%, compared to CV's ROE of +1.27%. Regarding short-term risk, DCTH is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CV's competition here
Picard Medical, Inc. (AMEX: PMI)
DCTH vs PMI Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, PMI has a market cap of 349.2M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while PMI trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas PMI's P/E ratio is -2.83. In terms of profitability, DCTH's ROE is +0.00%, compared to PMI's ROE of +4.99%. Regarding short-term risk, DCTH is more volatile compared to PMI. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check PMI's competition here
Electromed, Inc. (AMEX: ELMD)
DCTH vs ELMD Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ELMD has a market cap of 348.5M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ELMD trades at $42.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ELMD's P/E ratio is 35.97. In terms of profitability, DCTH's ROE is +0.00%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, DCTH is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ELMD's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
DCTH vs CATX Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, CATX has a market cap of 342.1M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while CATX trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas CATX's P/E ratio is -2.13. In terms of profitability, DCTH's ROE is +0.00%, compared to CATX's ROE of -0.42%. Regarding short-term risk, DCTH is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
DCTH vs SMLR Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas SMLR's P/E ratio is 3.92. In terms of profitability, DCTH's ROE is +0.00%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, DCTH is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
DCTH vs TMCI Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, TMCI has a market cap of 308.8M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while TMCI trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas TMCI's P/E ratio is -5.06. In terms of profitability, DCTH's ROE is +0.00%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, DCTH is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check TMCI's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
DCTH vs SENS Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, SENS has a market cap of 293.4M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while SENS trades at $7.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas SENS's P/E ratio is -3.51. In terms of profitability, DCTH's ROE is +0.00%, compared to SENS's ROE of -1.66%. Regarding short-term risk, DCTH is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check SENS's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
DCTH vs ANIK Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ANIK has a market cap of 286.7M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ANIK trades at $20.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ANIK's P/E ratio is 43.71. In terms of profitability, DCTH's ROE is +0.00%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, DCTH is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ANIK's competition here
Profound Medical Corp. (NASDAQ: PROF)
DCTH vs PROF Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, PROF has a market cap of 269.3M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while PROF trades at $7.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas PROF's P/E ratio is -5.98. In terms of profitability, DCTH's ROE is +0.00%, compared to PROF's ROE of -0.56%. Regarding short-term risk, DCTH is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
DCTH vs RXST Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, RXST has a market cap of 259.1M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while RXST trades at $6.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas RXST's P/E ratio is -6.73. In terms of profitability, DCTH's ROE is +0.00%, compared to RXST's ROE of -0.17%. Regarding short-term risk, DCTH is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check RXST's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
DCTH vs MGRM Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas MGRM's P/E ratio is -12.00. In terms of profitability, DCTH's ROE is +0.00%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, DCTH is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check MGRM's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
DCTH vs FOCL Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, FOCL has a market cap of 233.1M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while FOCL trades at $6.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas FOCL's P/E ratio is -8.00. In terms of profitability, DCTH's ROE is +0.00%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, DCTH is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check FOCL's competition here
Nevro Corp. (NYSE: NVRO)
DCTH vs NVRO Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas NVRO's P/E ratio is -1.91. In terms of profitability, DCTH's ROE is +0.00%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, DCTH is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check NVRO's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
DCTH vs TLSI Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, TLSI has a market cap of 212.7M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while TLSI trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas TLSI's P/E ratio is -3.34. In terms of profitability, DCTH's ROE is +0.00%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, DCTH is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check TLSI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
DCTH vs RCEL Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, RCEL has a market cap of 193M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while RCEL trades at $7.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas RCEL's P/E ratio is -4.95. In terms of profitability, DCTH's ROE is +0.00%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, DCTH is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
DCTH vs BSGM Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas BSGM's P/E ratio is -5.81. In terms of profitability, DCTH's ROE is +0.00%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, DCTH is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check BSGM's competition here
Quanterix Corporation (NASDAQ: QTRX)
DCTH vs QTRX Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, QTRX has a market cap of 189.8M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while QTRX trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas QTRX's P/E ratio is -2.52. In terms of profitability, DCTH's ROE is +0.00%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, DCTH is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check QTRX's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
DCTH vs MDGS Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas MDGS's P/E ratio is -0.27. In terms of profitability, DCTH's ROE is +0.00%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, DCTH is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
DCTH vs STIM Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, STIM has a market cap of 165.6M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while STIM trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas STIM's P/E ratio is -4.41. In terms of profitability, DCTH's ROE is +0.00%, compared to STIM's ROE of -1.65%. Regarding short-term risk, DCTH is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check STIM's competition here
Inogen, Inc. (NASDAQ: INGN)
DCTH vs INGN Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, INGN has a market cap of 163.8M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while INGN trades at $6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas INGN's P/E ratio is -6.65. In terms of profitability, DCTH's ROE is +0.00%, compared to INGN's ROE of -0.13%. Regarding short-term risk, DCTH is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check INGN's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
DCTH vs QIPT Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas QIPT's P/E ratio is -15.87. In terms of profitability, DCTH's ROE is +0.00%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, DCTH is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check QIPT's competition here
iCAD, Inc. (NASDAQ: ICAD)
DCTH vs ICAD Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas ICAD's P/E ratio is -20.37. In terms of profitability, DCTH's ROE is +0.00%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, DCTH is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
DCTH vs OWLT Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, OWLT has a market cap of 99.9M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while OWLT trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas OWLT's P/E ratio is -39.43. In terms of profitability, DCTH's ROE is +0.00%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, DCTH is more volatile compared to OWLT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check OWLT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
DCTH vs LUCD Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, LUCD has a market cap of 98.9M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while LUCD trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas LUCD's P/E ratio is -2.61. In terms of profitability, DCTH's ROE is +0.00%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, DCTH is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check LUCD's competition here
Solana Company (NASDAQ: HSDT)
DCTH vs HSDT Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, HSDT has a market cap of 98.7M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while HSDT trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas HSDT's P/E ratio is -0.02. In terms of profitability, DCTH's ROE is +0.00%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, DCTH is more volatile compared to HSDT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
DCTH vs HJLI Comparison August 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 521.6M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, DCTH is priced at $16.11 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1511.00, whereas HJLI's P/E ratio is N/A. In terms of profitability, DCTH's ROE is +0.00%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, DCTH is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check HJLI's competition here